Anti-SARS-CoV-2 Antibodies Persist for up to 13 Months and Reduce Risk of Reinfection

Floriane Gallais, Pierre Gantner, Timothée Bruel, Aurelie Velay, Delphine Planas, Marie-Josée Wendling, Sophie Bayer, Morgane Solis, Elodie Laugel, Nathalie Reix, Anne Schneider, Ludovic Glady, Baptiste Panaget, Nicolas Collongues, Marialuisa Partisani, Jean-Marc Lessinger, Arnaud Fontanet, David Rey, Yves Hansmann, Laurence Kling-Pillitteri, Olivier Schwartz, Jérome De Sèze, Nicolas Meyer, Maria Gonzalez, Catherine Schmidt-Mutter, Samira Fafi-Kremer
doi: https://doi.org/10.1101/2021.05.07.21256823

Article Information

doi 
https://doi.org/10.1101/2021.05.07.21256823
History 
  • May 15, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Floriane Gallais1,2,
  2. Pierre Gantner1,2,
  3. Timothée Bruel3,4,5,
  4. Aurelie Velay1,2,
  5. Delphine Planas3,4,5,
  6. Marie-Josée Wendling1,
  7. Sophie Bayer6,
  8. Morgane Solis1,2,
  9. Elodie Laugel1,2,
  10. Nathalie Reix6,
  11. Anne Schneider7,
  12. Ludovic Glady6,
  13. Baptiste Panaget1,2,
  14. Nicolas Collongues8,
  15. Marialuisa Partisani9,
  16. Jean-Marc Lessinger6,
  17. Arnaud Fontanet10,11,
  18. David Rey9,
  19. Yves Hansmann12,
  20. Laurence Kling-Pillitteri13,
  21. Olivier Schwartz3,4,5,
  22. Jérome De Sèze8,
  23. Nicolas Meyer14,
  24. Maria Gonzalez12,
  25. Catherine Schmidt-Mutter8 and
  26. Samira Fafi-Kremer1,2,*
  1. 1Virology Laboratory, Strasbourg University Hospital, Strasbourg, France
  2. 2Strasbourg University, INSERM, IRM UMR-S 1109, F-67000 Strasbourg, France
  3. 3Virus & Immunity Unit, Department of Virology, Institut Pasteur, Paris, France
  4. 4CNRS UMR 3569, Paris, France
  5. 5Vaccine Research Institute, Creteil, France
  6. 6CHU de Strasbourg, Laboratoire de Biochimie Clinique et Biologie Moléculaire, F-67091 Strasbourg, France
  7. 7CHU de Strasbourg, Département de Génétique Moléculaire du cancer, F-67091 Strasbourg, France
  8. 8Centre d’investigation Clinique INSERM 1434, CHU Strasbourg, France
  9. 9CHU de Strasbourg, Trait d’Union, F-67091 Strasbourg, France
  10. 10Emerging Diseases Epidemiology Unit, Department of Global Health, Institut Pasteur, Paris, France
  11. 11PACRI Unit, Conservatoire National des Arts et Métiers, Paris, France
  12. 12CHU de Strasbourg, Service des infectieuses et tropicales, F-67091 Strasbourg, France
  13. 13CHU de Strasbourg, Service de Pathologies Professionnelles, F-67091 Strasbourg, France
  14. 14CHU de Strasbourg, Service de santé Publique, GMRC, F-67091 Strasbourg, France
  1. ↵*Corresponding author.
    Prof Samira Fafi-Kremer, Virology Laboratory and INSERM UMR_S 1109, Strasbourg University Hospital, 3 rue Koeberlé, F-67000 Strasbourg, France; phone: (+33) 3 69 55 14 38; fax: (+33) 3 68 85 37 50, e-mail: samira.fafi-kremer{at}unistra.fr
Back to top
Posted May 15, 2021.
Download PDF
Data/Code
Email
Anti-SARS-CoV-2 Antibodies Persist for up to 13 Months and Reduce Risk of Reinfection
Floriane Gallais, Pierre Gantner, Timothée Bruel, Aurelie Velay, Delphine Planas, Marie-Josée Wendling, Sophie Bayer, Morgane Solis, Elodie Laugel, Nathalie Reix, Anne Schneider, Ludovic Glady, Baptiste Panaget, Nicolas Collongues, Marialuisa Partisani, Jean-Marc Lessinger, Arnaud Fontanet, David Rey, Yves Hansmann, Laurence Kling-Pillitteri, Olivier Schwartz, Jérome De Sèze, Nicolas Meyer, Maria Gonzalez, Catherine Schmidt-Mutter, Samira Fafi-Kremer
medRxiv 2021.05.07.21256823; doi: https://doi.org/10.1101/2021.05.07.21256823
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area